A Phase 3 Safety, Immunogenicity, Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317

Condition:   Chikungunya Virus Interventions:   Biological: CHIKV VLP/adjuvant;   Biological: Placebo Sponsor:   Emergent BioSolutions Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials